Delphi Bioscience strengthens growth plans with investment from PPM Oost
Delphi Bioscience, developer of innovative health screening solutions for women, has raised additional growth capital through an investment from PPM Oost. Match Plan acted as advisor and assisted Delphi Bioscience in attracting the required power. The investment enables the company to further develop its technology and strengthen its market position.
Smart screening solutions for women
Delphi Bioscience specializes in developing user-friendly screening solutions for vaginal and cervical infections. Through early detection, the company helps identify potential health problems, including cervical cancer, in a timely manner. Delphi's innovative technology contributes to improving women's healthcare and making preventive care more accessible and effective.
Capital as an engine for further growth
With PPM Oost's investment, Delphi Bioscience gains access to the resources needed to scale its technological solutions and tap into new markets. The partnership with a dedicated investor like PPM Oost also offers strategic support for the company's next growth phase.
Match Plan guides the investment process
Match Plan, under the responsibility of Hans van de Pas and Leon Koorevaar, advised Delphi Bioscience and managed the entire process of attracting investors. This included drafting an investment memorandum, selecting and approaching suitable participants, conducting interviews, and guiding the negotiations through to the closing of the transaction.
Deal team:
Related services
No obligation Advice
Over 30 years of experience
Please feel free to contact us
advisors for an introduction.
✔ Business sale
✔ Company takeover
✔ Acquisition financing
✔ Independent assessment